
Opinion|Videos|February 10, 2025
Managing Comorbidities and Mitigating Atopic March in Adolescent and Adult Patients
Panelists discuss managing comorbidities and mitigating atopic march in adolescent and adult patients, focusing on the importance of early intervention and coordinated care to prevent the progression of atopic diseases and improve long-term health outcomes.
Advertisement
Video content above is prompted by the following:
- How do the treatment options evolve as a child ages?
- FDA labeling (dupilumab ≥ 6 months, lebrikizumab ≥ 12 years, tralokinumab ≥ 12 years, abrocitinib ≥ 12 years, upadacitinib ≥ 12 years) vs off-label use
- How can the use of these systemic agents in pediatric patients potentially mitigate the atopic march? What can we do to halt the progression of pediatric atopic diseases?
- Lin 2024: A cohort taking dupilumab showed a significant risk reduction in atopic march (HR, 0.60 for developing asthma; HR, 0.69 for developing allergic rhinitis) in patients 18 years or younger vs conventional immunomodulatory care without dupilumab.
Advertisement
Related to this article

At AAP 2026, Peter Lio, MD, discussed distinguishing allergic and inflammatory skin conditions and when pediatricians should seek specialty care.

In national emergency department data from 2005 to 2024, fractures were the most common pediatric e-bike injury, and e-bikes had the second-highest admission rate.

An updated AAP policy statement renews the call to ban raw milk sales, citing pathogen risks to children and pregnant people and an emerging H5N1 concern.

A joinpoint analysis of 1991 to 2021 YRBSS data found suicidal ideation among US high school students declined through 2009, then increased through 2021.

Mark R. Corkins, MD, CNSC, FASPEN, AGAF, FAAP, reviews where pediatric probiotic evidence is strongest, why product quality varies, and which children should avoid them.

At AAP 2026, Carmen Tong, DO, discussed evaluating pediatric urinary symptoms and why behavioral strategies often come before medication.

A clinician-reported misinformation tracker at Children's Hospital of Philadelphia found vaccines accounted for 53.8% of 234 entries and informed education on 28 topics.
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Type 1 diabetes update: Immune therapy, screening, and new technology
2
Adolescent suicidal ideation trend reversed around 2009, analysis finds
3
What pediatricians should know about the 2026-27 AAP vaccine schedule
4
Constipation may be an overlooked driver of urinary symptoms in children
5

